Updates

This study discusses the evidence regarding buprenorphine dosing, noting the Food and Drug Administration’s (FDA) product label target dose of 16 mg/d. Early dose recommendations were based on mu receptor occupancy, and FDA buprenorphine literature states occupancy...

This study used data from the Longitudinal Prescription Database, which includes 92% of retail prescriptions in the US, to calculate rates of initiation of buprenorphine treatment and treatment retention (180 days or more of continuous treatment).  Researchers were...

The Justice Department’s Bureau of Justice Assistance (BJA), one of six program offices within the Office of Justice Programs (OJP), and the National Institute of Corrections (NIC) today announced the release of Guidelines for Managing Substance Withdrawal in Jails: A...

The Injury and Violence Prevention Branch of the Division of Public Health (IVPB) recently posted an update of suspected overdose deaths and provisional data on ED visits for overdose. The IVPB is able to share the year-end 2022 fentanyl-positive deaths report.  ...

Opioid overdose mortality has increased over the last ten years, but disproportionately among Black persons. The authors of this study examine racial disparities in receipt of buprenorphine and naloxone after opioid use disorder (OUD) related events using Medicare...